gener
recombin
vesicular
stomat
viru
vsv
pseudotyp
vsv
g
sg
replac
envelop
g
gene
gfp
gene
complement
spike
glycoprotein
sarscov
tran
neutral
infect
block
test
show
vsv
g
sg
sarscov
react
similarli
sarscov
specif
antiserum
suggest
g
sg
safe
replac
live
sarscov
neutral
test
cellentri
assay
handl
sever
acut
respiratori
syndrom
coronaviru
sar
cov
strictli
restrict
biosafeti
level
plu
laboratori
facil
limit
rel
research
vaccin
develop
spike
glycoprotein
mediat
sar
cov
attach
receptor
enter
host
cell
membran
fusion
induc
neutral
antibodi
studi
vesicular
stomat
viru
vsv
pseudotyp
bear
sar
cov
gener
replac
live
viru
establish
novel
rapid
safe
neutral
test
cellentri
assay
leader
sequenc
residu
codon
optim
gene
sar
cov
contain
residu
cytoplasm
tail
attach
amino
acid
within
cytoplasm
tail
mostli
close
transmembran
domain
vsv
g
protein
clone
pcagg
result
plasmid
pcaggssg
use
transfect
cell
surfac
express
confirm
indirect
fluoresc
assay
western
blot
gener
pseudotyp
recombin
vsv
sar
cov
vsv
g
sg
cell
transfect
pcaggssg
infect
recombin
vsv
vsv
g
g
open
read
frame
g
replac
green
fluoresc
protein
gfp
gene
complement
g
tran
three
hundr
tcid
sar
cov
infecti
unit
iu
vsv
g
sg
ad
twofold
dilut
sar
cov
specif
chicken
antisera
incub
hour
mixtur
contain
tcid
viru
iu
vsv
g
sg
ad
rins
vero
cell
triplic
well
plate
serum
specif
pathogen
free
spf
chicken
includ
neg
control
cell
infect
sar
cov
monitor
daili
cytopath
effect
day
neutral
titer
express
reciproc
highest
serum
dilut
fulli
inhibit
viru
replic
cell
infect
sar
cov
fulli
inhibit
gfp
express
cell
infect
vsv
g
sg
gfpposit
cell
count
hour
post
infect
fluoresc
microscop
gfp
express
infect
vero
cell
confirm
infecti
abil
vsv
g
sg
also
indic
viru
titer
rang
iuml
cell
supernat
polyclon
serum
sar
cov
block
infect
vsv
g
sgg
vero
viru
block
titer
similar
titer
block
live
sar
cov
result
indic
vsv
g
sg
safe
use
replac
live
sar
cov
sar
neutral
test
cellentri
assay
novel
vaccin
antivir
drug
develop
thank
dr
michael
f
provid
signal
sequenc
codon
optim
gene
sar
cov
dr
kawaoka
provid
pcagg
